Individual bioequivalence—a regulatory update-Reference-Cited by-同舟云学术

Individual bioequivalence—a regulatory update

Published:1997-01-01 Issue:1 Volume:7 Page:5-11
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Chen Mei-Ling¹

Affiliation:

1. a Division of Pharmaceutical Evaluation II Office of Clinical Pharmacology and Biopharmaceutics , Center for Drug Evaluation and Research Food and Drug Administration , 5600 Fishers Lane, Rockville, Maryland, 20857

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543409708835162

Reference16 articles.

1. The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs

2. Consideration of individual bioequivalence

3. Ekbohm , G. and Melander , H. 1990. “On variation, bioequivalence and interchangeability”. Uppsala: Department of Statistics, Swedish University of Agricultural Sciences. Report 14

4. Bioequivalence revisited

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing individual equivalence in parallel group and crossover designs: Exact test and sample size procedures;PLOS ONE;2022-05-27

2. Sample Size Calculations in Clinical Research: Third Edition;CH CRC BIOSTAT SER;2017-08-15

3. Pharmacological management of epilepsy;Progress in Neurology and Psychiatry;2016-03

4. Good Clinical Practice;Handbook of Bioequivalence Testing;2014-10-29

5. Multiple-Dose Bioequivalence Studies;Encyclopedia of Biopharmaceutical Statistics, Third Edition;2012-12-27